nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—stomach cancer—head and neck cancer	0.582	1	CtDrD
Irinotecan—ABCC1—Vinblastine—head and neck cancer	0.0399	0.148	CbGbCtD
Irinotecan—ABCC1—Docetaxel—head and neck cancer	0.0329	0.122	CbGbCtD
Irinotecan—ABCC2—Vinblastine—head and neck cancer	0.0295	0.109	CbGbCtD
Irinotecan—ABCG2—Fluorouracil—head and neck cancer	0.0288	0.107	CbGbCtD
Irinotecan—ABCC2—Docetaxel—head and neck cancer	0.0243	0.0901	CbGbCtD
Irinotecan—ABCG2—Docetaxel—head and neck cancer	0.022	0.0815	CbGbCtD
Irinotecan—ALB—Fluorouracil—head and neck cancer	0.0199	0.0735	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0162	0.0602	CbGbCtD
Irinotecan—CYP3A7—Docetaxel—head and neck cancer	0.0162	0.0602	CbGbCtD
Irinotecan—CYP3A5—Docetaxel—head and neck cancer	0.0122	0.0451	CbGbCtD
Irinotecan—ABCB1—Vinblastine—head and neck cancer	0.00962	0.0356	CbGbCtD
Irinotecan—ABCB1—Docetaxel—head and neck cancer	0.00793	0.0294	CbGbCtD
Irinotecan—CYP3A4—Vinblastine—head and neck cancer	0.00577	0.0214	CbGbCtD
Irinotecan—CYP3A4—Docetaxel—head and neck cancer	0.00475	0.0176	CbGbCtD
Irinotecan—Neutropenic enterocolitis—Docetaxel—head and neck cancer	0.00458	0.0532	CcSEcCtD
Irinotecan—Hand and foot syndrome secondary to sickle cell anaemia—Docetaxel—head and neck cancer	0.00458	0.0532	CcSEcCtD
Irinotecan—Neutropenic infection—Docetaxel—head and neck cancer	0.00458	0.0532	CcSEcCtD
Irinotecan—Neutropenic colitis—Docetaxel—head and neck cancer	0.00286	0.0333	CcSEcCtD
Irinotecan—Palmar-plantar erythrodysaesthesia syndrome—Docetaxel—head and neck cancer	0.00286	0.0333	CcSEcCtD
Irinotecan—Neutropenic sepsis—Fluorouracil—head and neck cancer	0.00263	0.0306	CcSEcCtD
Irinotecan—CES1—larynx—head and neck cancer	0.00199	0.121	CbGeAlD
Irinotecan—Ischaemia—Vinblastine—head and neck cancer	0.00191	0.0222	CcSEcCtD
Irinotecan—Neutropenic sepsis—Docetaxel—head and neck cancer	0.0019	0.0221	CcSEcCtD
Irinotecan—Lung infiltration—Hydroxyurea—head and neck cancer	0.00135	0.0157	CcSEcCtD
Irinotecan—Thromboembolic event—Docetaxel—head and neck cancer	0.00122	0.0142	CcSEcCtD
Irinotecan—Acute leukaemia—Docetaxel—head and neck cancer	0.00115	0.0134	CcSEcCtD
Irinotecan—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.00115	0.0133	CcSEcCtD
Irinotecan—Colitis ischaemic—Docetaxel—head and neck cancer	0.00112	0.013	CcSEcCtD
Irinotecan—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.00106	0.0123	CcSEcCtD
Irinotecan—TOP1—hair follicle—head and neck cancer	0.00105	0.064	CbGeAlD
Irinotecan—Hypomagnesaemia—Hydroxyurea—head and neck cancer	0.000999	0.0116	CcSEcCtD
Irinotecan—Ileus—Vinblastine—head and neck cancer	0.000983	0.0114	CcSEcCtD
Irinotecan—Sudden death—Fluorouracil—head and neck cancer	0.000893	0.0104	CcSEcCtD
Irinotecan—Extravasation—Vinblastine—head and neck cancer	0.000798	0.00927	CcSEcCtD
Irinotecan—Lacrimation—Fluorouracil—head and neck cancer	0.000777	0.00903	CcSEcCtD
Irinotecan—Febrile neutropenia—Fluorouracil—head and neck cancer	0.00076	0.00883	CcSEcCtD
Irinotecan—Ulcer—Hydroxyurea—head and neck cancer	0.000671	0.0078	CcSEcCtD
Irinotecan—Lymphopenia—Docetaxel—head and neck cancer	0.000644	0.00749	CcSEcCtD
Irinotecan—TOP1MT—thyroid gland—head and neck cancer	0.000638	0.0388	CbGeAlD
Irinotecan—SLC22A3—tongue—head and neck cancer	0.000637	0.0387	CbGeAlD
Irinotecan—Neoplasm—Vinblastine—head and neck cancer	0.000629	0.00732	CcSEcCtD
Irinotecan—Mucosal inflammation—Docetaxel—head and neck cancer	0.000596	0.00692	CcSEcCtD
Irinotecan—TOP1—parotid gland—head and neck cancer	0.000576	0.035	CbGeAlD
Irinotecan—Neoplasm—Hydroxyurea—head and neck cancer	0.000574	0.00667	CcSEcCtD
Irinotecan—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.000568	0.00661	CcSEcCtD
Irinotecan—TOP1MT—head—head and neck cancer	0.000566	0.0344	CbGeAlD
Irinotecan—Lacrimation—Docetaxel—head and neck cancer	0.000561	0.00652	CcSEcCtD
Irinotecan—TOP1—saliva-secreting gland—head and neck cancer	0.000551	0.0335	CbGeAlD
Irinotecan—Febrile neutropenia—Docetaxel—head and neck cancer	0.000548	0.00637	CcSEcCtD
Irinotecan—Speech disorder—Fluorouracil—head and neck cancer	0.000531	0.00618	CcSEcCtD
Irinotecan—CES1—neck—head and neck cancer	0.000528	0.0321	CbGeAlD
Irinotecan—Extravasation—Fluorouracil—head and neck cancer	0.000524	0.00609	CcSEcCtD
Irinotecan—CES2—parotid gland—head and neck cancer	0.000522	0.0317	CbGeAlD
Irinotecan—Cerebrovascular accident—Vinblastine—head and neck cancer	0.000516	0.00599	CcSEcCtD
Irinotecan—Embolism—Docetaxel—head and neck cancer	0.000514	0.00597	CcSEcCtD
Irinotecan—CES2—saliva-secreting gland—head and neck cancer	0.0005	0.0304	CbGeAlD
Irinotecan—Renal failure acute—Hydroxyurea—head and neck cancer	0.000499	0.0058	CcSEcCtD
Irinotecan—Lacrimation increased—Fluorouracil—head and neck cancer	0.000496	0.00576	CcSEcCtD
Irinotecan—Intestinal obstruction—Docetaxel—head and neck cancer	0.000484	0.00562	CcSEcCtD
Irinotecan—Dysarthria—Fluorouracil—head and neck cancer	0.000483	0.00562	CcSEcCtD
Irinotecan—Ulcer—Fluorouracil—head and neck cancer	0.000483	0.00562	CcSEcCtD
Irinotecan—Ileus—Docetaxel—head and neck cancer	0.000466	0.00542	CcSEcCtD
Irinotecan—ABCC1—hair follicle—head and neck cancer	0.000451	0.0274	CbGeAlD
Irinotecan—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.000432	0.00502	CcSEcCtD
Irinotecan—SLC22A3—mouth—head and neck cancer	0.000429	0.026	CbGeAlD
Irinotecan—Angina pectoris—Vinblastine—head and neck cancer	0.000425	0.00495	CcSEcCtD
Irinotecan—TOP1—trachea—head and neck cancer	0.000425	0.0258	CbGeAlD
Irinotecan—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00041	0.00477	CcSEcCtD
Irinotecan—Sepsis—Fluorouracil—head and neck cancer	0.000397	0.00461	CcSEcCtD
Irinotecan—TOP1MT—lymph node—head and neck cancer	0.000396	0.0241	CbGeAlD
Irinotecan—Pancreatitis—Hydroxyurea—head and neck cancer	0.00039	0.00454	CcSEcCtD
Irinotecan—CES2—trachea—head and neck cancer	0.000386	0.0234	CbGeAlD
Irinotecan—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000384	0.00446	CcSEcCtD
Irinotecan—Thrombophlebitis—Fluorouracil—head and neck cancer	0.000383	0.00445	CcSEcCtD
Irinotecan—Myocardial infarction—Vinblastine—head and neck cancer	0.000382	0.00444	CcSEcCtD
Irinotecan—CES1—connective tissue—head and neck cancer	0.000378	0.023	CbGeAlD
Irinotecan—Extravasation—Docetaxel—head and neck cancer	0.000378	0.00439	CcSEcCtD
Irinotecan—Neutropenia—Hydroxyurea—head and neck cancer	0.000372	0.00433	CcSEcCtD
Irinotecan—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000363	0.00422	CcSEcCtD
Irinotecan—Lacrimation increased—Docetaxel—head and neck cancer	0.000358	0.00416	CcSEcCtD
Irinotecan—Haemoglobin—Vinblastine—head and neck cancer	0.000351	0.00408	CcSEcCtD
Irinotecan—Haemorrhage—Vinblastine—head and neck cancer	0.00035	0.00406	CcSEcCtD
Irinotecan—Blood bilirubin increased—Docetaxel—head and neck cancer	0.000349	0.00405	CcSEcCtD
Irinotecan—Stomatitis—Hydroxyurea—head and neck cancer	0.000346	0.00402	CcSEcCtD
Irinotecan—TOP1—thyroid gland—head and neck cancer	0.000336	0.0204	CbGeAlD
Irinotecan—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000332	0.00386	CcSEcCtD
Irinotecan—Osteoarthritis—Fluorouracil—head and neck cancer	0.000332	0.00386	CcSEcCtD
Irinotecan—Pulmonary embolism—Docetaxel—head and neck cancer	0.00033	0.00383	CcSEcCtD
Irinotecan—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00033	0.00383	CcSEcCtD
Irinotecan—Haemoglobin—Hydroxyurea—head and neck cancer	0.00032	0.00372	CcSEcCtD
Irinotecan—Haemorrhage—Hydroxyurea—head and neck cancer	0.000319	0.00371	CcSEcCtD
Irinotecan—Colitis—Docetaxel—head and neck cancer	0.000317	0.00368	CcSEcCtD
Irinotecan—Cardiac arrest—Fluorouracil—head and neck cancer	0.000315	0.00367	CcSEcCtD
Irinotecan—Alopecia—Vinblastine—head and neck cancer	0.000309	0.00359	CcSEcCtD
Irinotecan—CES2—thyroid gland—head and neck cancer	0.000305	0.0185	CbGeAlD
Irinotecan—SLC22A3—parotid gland—head and neck cancer	0.000298	0.0181	CbGeAlD
Irinotecan—Neoplasm—Docetaxel—head and neck cancer	0.000298	0.00347	CcSEcCtD
Irinotecan—Angiopathy—Hydroxyurea—head and neck cancer	0.000289	0.00336	CcSEcCtD
Irinotecan—Sepsis—Docetaxel—head and neck cancer	0.000286	0.00333	CcSEcCtD
Irinotecan—Chills—Hydroxyurea—head and neck cancer	0.000286	0.00333	CcSEcCtD
Irinotecan—SLC22A3—saliva-secreting gland—head and neck cancer	0.000286	0.0174	CbGeAlD
Irinotecan—Ill-defined disorder—Vinblastine—head and neck cancer	0.000282	0.00328	CcSEcCtD
Irinotecan—Alopecia—Hydroxyurea—head and neck cancer	0.000282	0.00327	CcSEcCtD
Irinotecan—Anaemia—Vinblastine—head and neck cancer	0.000281	0.00327	CcSEcCtD
Irinotecan—Angina pectoris—Fluorouracil—head and neck cancer	0.000279	0.00325	CcSEcCtD
Irinotecan—CES1—lymphoid tissue—head and neck cancer	0.000277	0.0168	CbGeAlD
Irinotecan—Thrombophlebitis—Docetaxel—head and neck cancer	0.000277	0.00321	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000275	0.0032	CcSEcCtD
Irinotecan—Malaise—Vinblastine—head and neck cancer	0.000274	0.00319	CcSEcCtD
Irinotecan—Vertigo—Vinblastine—head and neck cancer	0.000273	0.00318	CcSEcCtD
Irinotecan—Leukopenia—Vinblastine—head and neck cancer	0.000272	0.00317	CcSEcCtD
Irinotecan—CES2—head—head and neck cancer	0.000271	0.0164	CbGeAlD
Irinotecan—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000266	0.0031	CcSEcCtD
Irinotecan—Hypertension—Vinblastine—head and neck cancer	0.000263	0.00305	CcSEcCtD
Irinotecan—SLC22A3—connective tissue—head and neck cancer	0.000263	0.016	CbGeAlD
Irinotecan—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000257	0.00299	CcSEcCtD
Irinotecan—Pneumonia—Fluorouracil—head and neck cancer	0.000257	0.00299	CcSEcCtD
Irinotecan—Anaemia—Hydroxyurea—head and neck cancer	0.000257	0.00298	CcSEcCtD
Irinotecan—Discomfort—Vinblastine—head and neck cancer	0.000256	0.00298	CcSEcCtD
Irinotecan—Visual disturbance—Docetaxel—head and neck cancer	0.000253	0.00294	CcSEcCtD
Irinotecan—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000252	0.00293	CcSEcCtD
Irinotecan—Renal impairment—Docetaxel—head and neck cancer	0.000252	0.00292	CcSEcCtD
Irinotecan—CES1—thyroid gland—head and neck cancer	0.000251	0.0153	CbGeAlD
Irinotecan—ACHE—thyroid gland—head and neck cancer	0.000251	0.0153	CbGeAlD
Irinotecan—Myocardial infarction—Fluorouracil—head and neck cancer	0.000251	0.00291	CcSEcCtD
Irinotecan—Malaise—Hydroxyurea—head and neck cancer	0.00025	0.00291	CcSEcCtD
Irinotecan—Stomatitis—Fluorouracil—head and neck cancer	0.000249	0.0029	CcSEcCtD
Irinotecan—Leukopenia—Hydroxyurea—head and neck cancer	0.000248	0.00289	CcSEcCtD
Irinotecan—ABCC1—parotid gland—head and neck cancer	0.000247	0.015	CbGeAlD
Irinotecan—Thrombocytopenia—Vinblastine—head and neck cancer	0.000243	0.00283	CcSEcCtD
Irinotecan—Hyponatraemia—Docetaxel—head and neck cancer	0.00024	0.00279	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000239	0.00278	CcSEcCtD
Irinotecan—Anorexia—Vinblastine—head and neck cancer	0.000237	0.00275	CcSEcCtD
Irinotecan—Discomfort—Hydroxyurea—head and neck cancer	0.000233	0.00271	CcSEcCtD
Irinotecan—Haemoglobin—Fluorouracil—head and neck cancer	0.000231	0.00268	CcSEcCtD
Irinotecan—Rhinitis—Fluorouracil—head and neck cancer	0.00023	0.00267	CcSEcCtD
Irinotecan—Haemorrhage—Fluorouracil—head and neck cancer	0.000229	0.00267	CcSEcCtD
Irinotecan—Oedema—Hydroxyurea—head and neck cancer	0.000226	0.00263	CcSEcCtD
Irinotecan—Infection—Hydroxyurea—head and neck cancer	0.000225	0.00262	CcSEcCtD
Irinotecan—Paraesthesia—Vinblastine—head and neck cancer	0.000223	0.00259	CcSEcCtD
Irinotecan—CES1—head—head and neck cancer	0.000223	0.0135	CbGeAlD
Irinotecan—Dehydration—Docetaxel—head and neck cancer	0.000223	0.00259	CcSEcCtD
Irinotecan—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000222	0.00258	CcSEcCtD
Irinotecan—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000222	0.00258	CcSEcCtD
Irinotecan—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000219	0.00254	CcSEcCtD
Irinotecan—Anorexia—Hydroxyurea—head and neck cancer	0.000216	0.00251	CcSEcCtD
Irinotecan—Decreased appetite—Vinblastine—head and neck cancer	0.000216	0.00251	CcSEcCtD
Irinotecan—Cramp muscle—Docetaxel—head and neck cancer	0.000216	0.00251	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000216	0.00251	CcSEcCtD
Irinotecan—Pain—Vinblastine—head and neck cancer	0.000212	0.00247	CcSEcCtD
Irinotecan—Constipation—Vinblastine—head and neck cancer	0.000212	0.00247	CcSEcCtD
Irinotecan—TOP1—lymph node—head and neck cancer	0.000209	0.0127	CbGeAlD
Irinotecan—Arrhythmia—Fluorouracil—head and neck cancer	0.000205	0.00238	CcSEcCtD
Irinotecan—Feeling abnormal—Vinblastine—head and neck cancer	0.000205	0.00238	CcSEcCtD
Irinotecan—ABCG2—parotid gland—head and neck cancer	0.000204	0.0124	CbGeAlD
Irinotecan—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000203	0.00236	CcSEcCtD
Irinotecan—Alopecia—Fluorouracil—head and neck cancer	0.000203	0.00236	CcSEcCtD
Irinotecan—Dyspnoea—Hydroxyurea—head and neck cancer	0.000202	0.00235	CcSEcCtD
Irinotecan—Angina pectoris—Docetaxel—head and neck cancer	0.000202	0.00234	CcSEcCtD
Irinotecan—Somnolence—Hydroxyurea—head and neck cancer	0.000201	0.00234	CcSEcCtD
Irinotecan—Dyspepsia—Hydroxyurea—head and neck cancer	0.000199	0.00232	CcSEcCtD
Irinotecan—Decreased appetite—Hydroxyurea—head and neck cancer	0.000197	0.00229	CcSEcCtD
Irinotecan—Abdominal pain—Vinblastine—head and neck cancer	0.000196	0.00228	CcSEcCtD
Irinotecan—ABCG2—saliva-secreting gland—head and neck cancer	0.000196	0.0119	CbGeAlD
Irinotecan—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000196	0.00227	CcSEcCtD
Irinotecan—Fatigue—Hydroxyurea—head and neck cancer	0.000195	0.00227	CcSEcCtD
Irinotecan—Constipation—Hydroxyurea—head and neck cancer	0.000194	0.00225	CcSEcCtD
Irinotecan—Pain—Hydroxyurea—head and neck cancer	0.000194	0.00225	CcSEcCtD
Irinotecan—Neutropenia—Docetaxel—head and neck cancer	0.000193	0.00225	CcSEcCtD
Irinotecan—CES2—lymph node—head and neck cancer	0.00019	0.0115	CbGeAlD
Irinotecan—Weight decreased—Docetaxel—head and neck cancer	0.000187	0.00218	CcSEcCtD
Irinotecan—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000187	0.00217	CcSEcCtD
Irinotecan—Pneumonia—Docetaxel—head and neck cancer	0.000186	0.00216	CcSEcCtD
Irinotecan—Anaemia—Fluorouracil—head and neck cancer	0.000185	0.00215	CcSEcCtD
Irinotecan—Hypersensitivity—Vinblastine—head and neck cancer	0.000183	0.00213	CcSEcCtD
Irinotecan—ABCC1—trachea—head and neck cancer	0.000182	0.0111	CbGeAlD
Irinotecan—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000182	0.00211	CcSEcCtD
Irinotecan—Renal failure—Docetaxel—head and neck cancer	0.000181	0.00211	CcSEcCtD
Irinotecan—Myocardial infarction—Docetaxel—head and neck cancer	0.000181	0.0021	CcSEcCtD
Irinotecan—Stomatitis—Docetaxel—head and neck cancer	0.00018	0.00209	CcSEcCtD
Irinotecan—Jaundice—Docetaxel—head and neck cancer	0.00018	0.00209	CcSEcCtD
Irinotecan—Body temperature increased—Hydroxyurea—head and neck cancer	0.000179	0.00208	CcSEcCtD
Irinotecan—Leukopenia—Fluorouracil—head and neck cancer	0.000179	0.00208	CcSEcCtD
Irinotecan—Asthenia—Vinblastine—head and neck cancer	0.000178	0.00207	CcSEcCtD
Irinotecan—SLC22A3—thyroid gland—head and neck cancer	0.000174	0.0106	CbGeAlD
Irinotecan—Diarrhoea—Vinblastine—head and neck cancer	0.00017	0.00198	CcSEcCtD
Irinotecan—Discomfort—Fluorouracil—head and neck cancer	0.000168	0.00195	CcSEcCtD
Irinotecan—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000167	0.00194	CcSEcCtD
Irinotecan—Haemoglobin—Docetaxel—head and neck cancer	0.000166	0.00194	CcSEcCtD
Irinotecan—Rhinitis—Docetaxel—head and neck cancer	0.000166	0.00193	CcSEcCtD
Irinotecan—Haemorrhage—Docetaxel—head and neck cancer	0.000166	0.00193	CcSEcCtD
Irinotecan—Confusional state—Fluorouracil—head and neck cancer	0.000164	0.00191	CcSEcCtD
Irinotecan—Dizziness—Vinblastine—head and neck cancer	0.000164	0.00191	CcSEcCtD
Irinotecan—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000163	0.0019	CcSEcCtD
Irinotecan—Oedema—Fluorouracil—head and neck cancer	0.000163	0.0019	CcSEcCtD
Irinotecan—Connective tissue disorder—Docetaxel—head and neck cancer	0.000163	0.00189	CcSEcCtD
Irinotecan—Asthenia—Hydroxyurea—head and neck cancer	0.000163	0.00189	CcSEcCtD
Irinotecan—Infection—Fluorouracil—head and neck cancer	0.000162	0.00188	CcSEcCtD
Irinotecan—Nervous system disorder—Fluorouracil—head and neck cancer	0.00016	0.00186	CcSEcCtD
Irinotecan—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00016	0.00186	CcSEcCtD
Irinotecan—Visual impairment—Docetaxel—head and neck cancer	0.00016	0.00186	CcSEcCtD
Irinotecan—Vomiting—Vinblastine—head and neck cancer	0.000158	0.00184	CcSEcCtD
Irinotecan—BCHE—trachea—head and neck cancer	0.000156	0.00949	CbGeAlD
Irinotecan—ACHE—lymph node—head and neck cancer	0.000156	0.00948	CbGeAlD
Irinotecan—CES1—lymph node—head and neck cancer	0.000156	0.00948	CbGeAlD
Irinotecan—Headache—Vinblastine—head and neck cancer	0.000156	0.00181	CcSEcCtD
Irinotecan—Anorexia—Fluorouracil—head and neck cancer	0.000155	0.00181	CcSEcCtD
Irinotecan—Diarrhoea—Hydroxyurea—head and neck cancer	0.000155	0.0018	CcSEcCtD
Irinotecan—SLC22A3—head—head and neck cancer	0.000155	0.0094	CbGeAlD
Irinotecan—Flushing—Docetaxel—head and neck cancer	0.000154	0.00179	CcSEcCtD
Irinotecan—Cardiac disorder—Docetaxel—head and neck cancer	0.000154	0.00179	CcSEcCtD
Irinotecan—Hypotension—Fluorouracil—head and neck cancer	0.000152	0.00177	CcSEcCtD
Irinotecan—Angiopathy—Docetaxel—head and neck cancer	0.00015	0.00175	CcSEcCtD
Irinotecan—Dizziness—Hydroxyurea—head and neck cancer	0.00015	0.00174	CcSEcCtD
Irinotecan—Immune system disorder—Docetaxel—head and neck cancer	0.00015	0.00174	CcSEcCtD
Irinotecan—Mediastinal disorder—Docetaxel—head and neck cancer	0.000149	0.00174	CcSEcCtD
Irinotecan—Chills—Docetaxel—head and neck cancer	0.000149	0.00173	CcSEcCtD
Irinotecan—Arrhythmia—Docetaxel—head and neck cancer	0.000148	0.00172	CcSEcCtD
Irinotecan—Nausea—Vinblastine—head and neck cancer	0.000148	0.00171	CcSEcCtD
Irinotecan—Insomnia—Fluorouracil—head and neck cancer	0.000147	0.00171	CcSEcCtD
Irinotecan—Paraesthesia—Fluorouracil—head and neck cancer	0.000146	0.0017	CcSEcCtD
Irinotecan—Alopecia—Docetaxel—head and neck cancer	0.000146	0.0017	CcSEcCtD
Irinotecan—Dyspnoea—Fluorouracil—head and neck cancer	0.000145	0.00169	CcSEcCtD
Irinotecan—Somnolence—Fluorouracil—head and neck cancer	0.000145	0.00168	CcSEcCtD
Irinotecan—ABCC1—thyroid gland—head and neck cancer	0.000144	0.00876	CbGeAlD
Irinotecan—Vomiting—Hydroxyurea—head and neck cancer	0.000144	0.00167	CcSEcCtD
Irinotecan—Dyspepsia—Fluorouracil—head and neck cancer	0.000144	0.00167	CcSEcCtD
Irinotecan—Rash—Hydroxyurea—head and neck cancer	0.000143	0.00166	CcSEcCtD
Irinotecan—Dermatitis—Hydroxyurea—head and neck cancer	0.000143	0.00166	CcSEcCtD
Irinotecan—Headache—Hydroxyurea—head and neck cancer	0.000142	0.00165	CcSEcCtD
Irinotecan—Decreased appetite—Fluorouracil—head and neck cancer	0.000142	0.00165	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000141	0.00164	CcSEcCtD
Irinotecan—Back pain—Docetaxel—head and neck cancer	0.000139	0.00162	CcSEcCtD
Irinotecan—Pain—Fluorouracil—head and neck cancer	0.000139	0.00162	CcSEcCtD
Irinotecan—Muscle spasms—Docetaxel—head and neck cancer	0.000139	0.00161	CcSEcCtD
Irinotecan—Nausea—Hydroxyurea—head and neck cancer	0.000135	0.00156	CcSEcCtD
Irinotecan—Feeling abnormal—Fluorouracil—head and neck cancer	0.000134	0.00156	CcSEcCtD
Irinotecan—Anaemia—Docetaxel—head and neck cancer	0.000133	0.00155	CcSEcCtD
Irinotecan—Syncope—Docetaxel—head and neck cancer	0.000129	0.0015	CcSEcCtD
Irinotecan—Leukopenia—Docetaxel—head and neck cancer	0.000129	0.0015	CcSEcCtD
Irinotecan—Body temperature increased—Fluorouracil—head and neck cancer	0.000129	0.0015	CcSEcCtD
Irinotecan—Loss of consciousness—Docetaxel—head and neck cancer	0.000127	0.00147	CcSEcCtD
Irinotecan—Cough—Docetaxel—head and neck cancer	0.000126	0.00146	CcSEcCtD
Irinotecan—Hypertension—Docetaxel—head and neck cancer	0.000124	0.00145	CcSEcCtD
Irinotecan—BCHE—thyroid gland—head and neck cancer	0.000124	0.0075	CbGeAlD
Irinotecan—CYP2B6—lymphoid tissue—head and neck cancer	0.000121	0.00737	CbGeAlD
Irinotecan—Hypersensitivity—Fluorouracil—head and neck cancer	0.00012	0.0014	CcSEcCtD
Irinotecan—ABCG2—thyroid gland—head and neck cancer	0.000119	0.00725	CbGeAlD
Irinotecan—Confusional state—Docetaxel—head and neck cancer	0.000119	0.00138	CcSEcCtD
Irinotecan—Oedema—Docetaxel—head and neck cancer	0.000118	0.00137	CcSEcCtD
Irinotecan—Anaphylactic shock—Docetaxel—head and neck cancer	0.000118	0.00137	CcSEcCtD
Irinotecan—Infection—Docetaxel—head and neck cancer	0.000117	0.00136	CcSEcCtD
Irinotecan—Shock—Docetaxel—head and neck cancer	0.000116	0.00135	CcSEcCtD
Irinotecan—Nervous system disorder—Docetaxel—head and neck cancer	0.000115	0.00134	CcSEcCtD
Irinotecan—Thrombocytopenia—Docetaxel—head and neck cancer	0.000115	0.00134	CcSEcCtD
Irinotecan—Anorexia—Docetaxel—head and neck cancer	0.000112	0.0013	CcSEcCtD
Irinotecan—Diarrhoea—Fluorouracil—head and neck cancer	0.000112	0.0013	CcSEcCtD
Irinotecan—Hypotension—Docetaxel—head and neck cancer	0.00011	0.00128	CcSEcCtD
Irinotecan—BCHE—head—head and neck cancer	0.00011	0.00666	CbGeAlD
Irinotecan—ALB—lymph node—head and neck cancer	0.000109	0.00659	CbGeAlD
Irinotecan—SLC22A3—lymph node—head and neck cancer	0.000108	0.00658	CbGeAlD
Irinotecan—Dizziness—Fluorouracil—head and neck cancer	0.000108	0.00125	CcSEcCtD
Irinotecan—Insomnia—Docetaxel—head and neck cancer	0.000106	0.00124	CcSEcCtD
Irinotecan—Paraesthesia—Docetaxel—head and neck cancer	0.000106	0.00123	CcSEcCtD
Irinotecan—Dyspnoea—Docetaxel—head and neck cancer	0.000105	0.00122	CcSEcCtD
Irinotecan—Somnolence—Docetaxel—head and neck cancer	0.000105	0.00122	CcSEcCtD
Irinotecan—Vomiting—Fluorouracil—head and neck cancer	0.000104	0.0012	CcSEcCtD
Irinotecan—Dyspepsia—Docetaxel—head and neck cancer	0.000104	0.0012	CcSEcCtD
Irinotecan—Rash—Fluorouracil—head and neck cancer	0.000103	0.00119	CcSEcCtD
Irinotecan—Dermatitis—Fluorouracil—head and neck cancer	0.000103	0.00119	CcSEcCtD
Irinotecan—Decreased appetite—Docetaxel—head and neck cancer	0.000102	0.00119	CcSEcCtD
Irinotecan—Headache—Fluorouracil—head and neck cancer	0.000102	0.00119	CcSEcCtD
Irinotecan—ABCC2—lymph node—head and neck cancer	0.000102	0.00618	CbGeAlD
Irinotecan—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000102	0.00118	CcSEcCtD
Irinotecan—Fatigue—Docetaxel—head and neck cancer	0.000101	0.00118	CcSEcCtD
Irinotecan—Pain—Docetaxel—head and neck cancer	0.000101	0.00117	CcSEcCtD
Irinotecan—Constipation—Docetaxel—head and neck cancer	0.000101	0.00117	CcSEcCtD
Irinotecan—CYP2B6—head—head and neck cancer	9.77e-05	0.00594	CbGeAlD
Irinotecan—Feeling abnormal—Docetaxel—head and neck cancer	9.7e-05	0.00113	CcSEcCtD
Irinotecan—Nausea—Fluorouracil—head and neck cancer	9.68e-05	0.00113	CcSEcCtD
Irinotecan—Gastrointestinal pain—Docetaxel—head and neck cancer	9.62e-05	0.00112	CcSEcCtD
Irinotecan—Body temperature increased—Docetaxel—head and neck cancer	9.3e-05	0.00108	CcSEcCtD
Irinotecan—Abdominal pain—Docetaxel—head and neck cancer	9.3e-05	0.00108	CcSEcCtD
Irinotecan—ABCC1—lymph node—head and neck cancer	8.96e-05	0.00544	CbGeAlD
Irinotecan—Hypersensitivity—Docetaxel—head and neck cancer	8.67e-05	0.00101	CcSEcCtD
Irinotecan—Asthenia—Docetaxel—head and neck cancer	8.44e-05	0.000981	CcSEcCtD
Irinotecan—ABCB1—epithelium—head and neck cancer	8.41e-05	0.00511	CbGeAlD
Irinotecan—Diarrhoea—Docetaxel—head and neck cancer	8.05e-05	0.000936	CcSEcCtD
Irinotecan—Dizziness—Docetaxel—head and neck cancer	7.78e-05	0.000905	CcSEcCtD
Irinotecan—BCHE—lymph node—head and neck cancer	7.67e-05	0.00466	CbGeAlD
Irinotecan—Vomiting—Docetaxel—head and neck cancer	7.48e-05	0.00087	CcSEcCtD
Irinotecan—ABCB1—trachea—head and neck cancer	7.44e-05	0.00452	CbGeAlD
Irinotecan—Rash—Docetaxel—head and neck cancer	7.42e-05	0.000862	CcSEcCtD
Irinotecan—ABCG2—lymph node—head and neck cancer	7.41e-05	0.00451	CbGeAlD
Irinotecan—Dermatitis—Docetaxel—head and neck cancer	7.41e-05	0.000862	CcSEcCtD
Irinotecan—Headache—Docetaxel—head and neck cancer	7.37e-05	0.000857	CcSEcCtD
Irinotecan—Nausea—Docetaxel—head and neck cancer	6.99e-05	0.000812	CcSEcCtD
Irinotecan—ABCB1—lymphoid tissue—head and neck cancer	6.48e-05	0.00394	CbGeAlD
Irinotecan—ABCB1—thyroid gland—head and neck cancer	5.89e-05	0.00358	CbGeAlD
Irinotecan—ABCB1—head—head and neck cancer	5.22e-05	0.00317	CbGeAlD
Irinotecan—ABCB1—lymph node—head and neck cancer	3.66e-05	0.00222	CbGeAlD
Irinotecan—ACHE—Phospholipid metabolism—PIK3CA—head and neck cancer	2.88e-05	0.000629	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	2.84e-05	0.000621	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	2.83e-05	0.000619	CbGpPWpGaD
Irinotecan—ALB—Platelet degranulation—VEGFA—head and neck cancer	2.83e-05	0.000619	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	2.82e-05	0.000616	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	2.7e-05	0.00059	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.69e-05	0.000587	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—DPYD—head and neck cancer	2.68e-05	0.000587	CbGpPWpGaD
Irinotecan—BCHE—Phospholipid metabolism—PIK3CA—head and neck cancer	2.57e-05	0.000561	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.56e-05	0.000559	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.56e-05	0.000559	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.56e-05	0.000559	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—YAP1—head and neck cancer	2.55e-05	0.000557	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.53e-05	0.000554	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—UROD—head and neck cancer	2.52e-05	0.000552	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	2.51e-05	0.000548	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—TP53—head and neck cancer	2.5e-05	0.000545	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—MAPK1—head and neck cancer	2.46e-05	0.000539	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.43e-05	0.000531	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—NAT2—head and neck cancer	2.41e-05	0.000527	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.4e-05	0.000525	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.34e-05	0.000512	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.32e-05	0.000506	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—NAT2—head and neck cancer	2.29e-05	0.0005	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—NAT2—head and neck cancer	2.29e-05	0.0005	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.28e-05	0.000499	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.26e-05	0.000494	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.24e-05	0.000489	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.22e-05	0.000486	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.22e-05	0.000485	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—NAT2—head and neck cancer	2.2e-05	0.000482	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.2e-05	0.000481	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—MAPK1—head and neck cancer	2.2e-05	0.000481	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—NAT2—head and neck cancer	2.15e-05	0.00047	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.15e-05	0.000469	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—DPYD—head and neck cancer	2.11e-05	0.000462	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—NAT2—head and neck cancer	2.09e-05	0.000458	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—YAP1—head and neck cancer	2e-05	0.000438	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—DPYD—head and neck cancer	2e-05	0.000438	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—DPYD—head and neck cancer	2e-05	0.000438	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—HRAS—head and neck cancer	1.98e-05	0.000432	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—NAT2—head and neck cancer	1.94e-05	0.000424	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—DPYD—head and neck cancer	1.93e-05	0.000422	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	1.93e-05	0.000421	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—NAT2—head and neck cancer	1.92e-05	0.00042	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—YAP1—head and neck cancer	1.9e-05	0.000416	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—YAP1—head and neck cancer	1.9e-05	0.000416	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—MAPK1—head and neck cancer	1.89e-05	0.000413	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—DPYD—head and neck cancer	1.88e-05	0.000412	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.87e-05	0.000408	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	1.85e-05	0.000404	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.84e-05	0.000402	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—DPYD—head and neck cancer	1.84e-05	0.000401	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—YAP1—head and neck cancer	1.83e-05	0.000401	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.81e-05	0.000396	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—YAP1—head and neck cancer	1.79e-05	0.000391	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.77e-05	0.000387	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—HRAS—head and neck cancer	1.77e-05	0.000386	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.74e-05	0.000381	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—YAP1—head and neck cancer	1.74e-05	0.000381	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—DPYD—head and neck cancer	1.7e-05	0.000372	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—DPYD—head and neck cancer	1.69e-05	0.000368	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—MAPK1—head and neck cancer	1.68e-05	0.000368	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.65e-05	0.000361	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—YAP1—head and neck cancer	1.61e-05	0.000353	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—YAP1—head and neck cancer	1.6e-05	0.00035	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.57e-05	0.000343	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—UROD—head and neck cancer	1.56e-05	0.00034	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—TYMS—head and neck cancer	1.53e-05	0.000334	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—HRAS—head and neck cancer	1.52e-05	0.000331	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GSTM1—head and neck cancer	1.51e-05	0.00033	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.51e-05	0.000329	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	1.48e-05	0.000323	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GPX1—head and neck cancer	1.45e-05	0.000316	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CYP1A1—head and neck cancer	1.43e-05	0.000313	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.43e-05	0.000312	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—NAT2—head and neck cancer	1.42e-05	0.000311	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.42e-05	0.00031	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—NAT2—head and neck cancer	1.39e-05	0.000304	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.38e-05	0.000301	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.37e-05	0.000299	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—HRAS—head and neck cancer	1.35e-05	0.000296	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.34e-05	0.000294	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.31e-05	0.000287	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.31e-05	0.000286	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.27e-05	0.000278	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.26e-05	0.000275	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	1.26e-05	0.000275	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—DPYD—head and neck cancer	1.25e-05	0.000272	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.25e-05	0.000272	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.24e-05	0.00027	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—DPYD—head and neck cancer	1.22e-05	0.000266	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—TYMS—head and neck cancer	1.2e-05	0.000263	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.2e-05	0.000263	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NAT2—head and neck cancer	1.2e-05	0.000262	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GSTM1—head and neck cancer	1.19e-05	0.00026	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	1.19e-05	0.00026	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—YAP1—head and neck cancer	1.18e-05	0.000259	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.17e-05	0.000256	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.17e-05	0.000256	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—YAP1—head and neck cancer	1.16e-05	0.000253	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—TYMS—head and neck cancer	1.14e-05	0.00025	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—TYMS—head and neck cancer	1.14e-05	0.00025	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.14e-05	0.00025	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GPX1—head and neck cancer	1.14e-05	0.000249	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	1.13e-05	0.000247	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GSTM1—head and neck cancer	1.13e-05	0.000247	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GSTM1—head and neck cancer	1.13e-05	0.000247	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CYP1A1—head and neck cancer	1.13e-05	0.000247	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.11e-05	0.000243	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.11e-05	0.000243	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—TYMS—head and neck cancer	1.1e-05	0.000241	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GSTM1—head and neck cancer	1.09e-05	0.000238	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GPX1—head and neck cancer	1.08e-05	0.000236	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GPX1—head and neck cancer	1.08e-05	0.000236	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—TYMS—head and neck cancer	1.07e-05	0.000235	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CYP1A1—head and neck cancer	1.07e-05	0.000234	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CYP1A1—head and neck cancer	1.07e-05	0.000234	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GSTM1—head and neck cancer	1.06e-05	0.000232	CbGpPWpGaD
Irinotecan—ALB—Metabolism—DPYD—head and neck cancer	1.05e-05	0.000229	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NAT2—head and neck cancer	1.05e-05	0.000229	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—TYMS—head and neck cancer	1.05e-05	0.000229	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GPX1—head and neck cancer	1.04e-05	0.000228	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GSTM1—head and neck cancer	1.03e-05	0.000226	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CYP1A1—head and neck cancer	1.03e-05	0.000226	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GPX1—head and neck cancer	1.02e-05	0.000222	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CYP1A1—head and neck cancer	1.01e-05	0.00022	CbGpPWpGaD
Irinotecan—ALB—Metabolism—YAP1—head and neck cancer	9.96e-06	0.000218	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GPX1—head and neck cancer	9.91e-06	0.000217	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NOTCH1—head and neck cancer	9.87e-06	0.000216	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	9.81e-06	0.000214	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	9.81e-06	0.000214	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—TYMS—head and neck cancer	9.69e-06	0.000212	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	9.66e-06	0.000211	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—TYMS—head and neck cancer	9.6e-06	0.00021	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GSTM1—head and neck cancer	9.58e-06	0.000209	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GSTM1—head and neck cancer	9.49e-06	0.000208	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	9.34e-06	0.000204	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.26e-06	0.000203	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—DPYD—head and neck cancer	9.19e-06	0.000201	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GPX1—head and neck cancer	9.17e-06	0.0002	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GPX1—head and neck cancer	9.09e-06	0.000199	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CYP1A1—head and neck cancer	9.08e-06	0.000198	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CYP1A1—head and neck cancer	9e-06	0.000197	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.79e-06	0.000192	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—YAP1—head and neck cancer	8.72e-06	0.000191	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTGS2—head and neck cancer	8.52e-06	0.000186	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.48e-06	0.000185	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.27e-06	0.000181	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.06e-06	0.000176	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	8.01e-06	0.000175	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	7.89e-06	0.000172	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IL2—head and neck cancer	7.62e-06	0.000166	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.48e-06	0.000164	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTEN—head and neck cancer	7.43e-06	0.000162	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—head and neck cancer	7.33e-06	0.00016	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TYMS—head and neck cancer	7.1e-06	0.000155	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTM1—head and neck cancer	7.02e-06	0.000153	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TYMS—head and neck cancer	6.94e-06	0.000152	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTM1—head and neck cancer	6.86e-06	0.00015	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GPX1—head and neck cancer	6.72e-06	0.000147	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—head and neck cancer	6.71e-06	0.000147	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP1A1—head and neck cancer	6.66e-06	0.000145	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GPX1—head and neck cancer	6.57e-06	0.000144	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.52e-06	0.000143	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP1A1—head and neck cancer	6.51e-06	0.000142	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—head and neck cancer	6.47e-06	0.000141	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NAT2—head and neck cancer	6.46e-06	0.000141	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTEN—head and neck cancer	6.39e-06	0.00014	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—head and neck cancer	6.36e-06	0.000139	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—head and neck cancer	6.36e-06	0.000139	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—head and neck cancer	6.14e-06	0.000134	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK3—head and neck cancer	6.12e-06	0.000134	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—head and neck cancer	5.98e-06	0.000131	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TYMS—head and neck cancer	5.98e-06	0.000131	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTM1—head and neck cancer	5.91e-06	0.000129	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTEN—head and neck cancer	5.85e-06	0.000128	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—head and neck cancer	5.83e-06	0.000127	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK1—head and neck cancer	5.83e-06	0.000127	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STAT3—head and neck cancer	5.71e-06	0.000125	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—DPYD—head and neck cancer	5.66e-06	0.000124	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GPX1—head and neck cancer	5.66e-06	0.000124	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP1A1—head and neck cancer	5.6e-06	0.000122	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTEN—head and neck cancer	5.55e-06	0.000121	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTEN—head and neck cancer	5.55e-06	0.000121	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK3—head and neck cancer	5.46e-06	0.000119	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—head and neck cancer	5.4e-06	0.000118	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—YAP1—head and neck cancer	5.37e-06	0.000117	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—head and neck cancer	5.35e-06	0.000117	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTEN—head and neck cancer	5.35e-06	0.000117	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CA—head and neck cancer	5.24e-06	0.000115	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TYMS—head and neck cancer	5.24e-06	0.000115	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTEN—head and neck cancer	5.22e-06	0.000114	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK1—head and neck cancer	5.19e-06	0.000114	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—head and neck cancer	5.19e-06	0.000114	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTM1—head and neck cancer	5.18e-06	0.000113	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTEN—head and neck cancer	5.09e-06	0.000111	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CA—head and neck cancer	5.06e-06	0.000111	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GPX1—head and neck cancer	4.96e-06	0.000108	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP1A1—head and neck cancer	4.91e-06	0.000107	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—head and neck cancer	4.89e-06	0.000107	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTEN—head and neck cancer	4.71e-06	0.000103	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—head and neck cancer	4.68e-06	0.000102	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTEN—head and neck cancer	4.67e-06	0.000102	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.6e-06	0.000101	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CA—head and neck cancer	4.51e-06	9.85e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—head and neck cancer	4.28e-06	9.36e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—head and neck cancer	4.17e-06	9.12e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—head and neck cancer	4.13e-06	9.03e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CA—head and neck cancer	4.13e-06	9.02e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—head and neck cancer	3.96e-06	8.65e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CA—head and neck cancer	3.92e-06	8.56e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CA—head and neck cancer	3.92e-06	8.56e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—head and neck cancer	3.87e-06	8.46e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CA—head and neck cancer	3.78e-06	8.25e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—head and neck cancer	3.68e-06	8.05e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CA—head and neck cancer	3.68e-06	8.05e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	3.59e-06	7.84e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTEN—head and neck cancer	3.45e-06	7.55e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTEN—head and neck cancer	3.37e-06	7.38e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—head and neck cancer	3.37e-06	7.37e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—head and neck cancer	3.33e-06	7.28e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CA—head and neck cancer	3.32e-06	7.26e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CA—head and neck cancer	3.29e-06	7.2e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TYMS—head and neck cancer	3.23e-06	7.06e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—head and neck cancer	3.2e-06	6.99e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—head and neck cancer	3.2e-06	6.99e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTM1—head and neck cancer	3.19e-06	6.97e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—head and neck cancer	3.08e-06	6.74e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GPX1—head and neck cancer	3.06e-06	6.68e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.02e-06	6.61e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—head and neck cancer	3.01e-06	6.57e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—head and neck cancer	2.93e-06	6.41e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—head and neck cancer	2.92e-06	6.38e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTEN—head and neck cancer	2.91e-06	6.35e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—head and neck cancer	2.71e-06	5.93e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—head and neck cancer	2.69e-06	5.88e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTEN—head and neck cancer	2.55e-06	5.57e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CA—head and neck cancer	2.44e-06	5.32e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CA—head and neck cancer	2.38e-06	5.2e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CA—head and neck cancer	2.05e-06	4.48e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—head and neck cancer	1.99e-06	4.35e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—head and neck cancer	1.94e-06	4.25e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.8e-06	3.93e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.8e-06	3.93e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—head and neck cancer	1.67e-06	3.66e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTEN—head and neck cancer	1.57e-06	3.43e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—head and neck cancer	1.47e-06	3.21e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.11e-06	2.42e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—head and neck cancer	9.04e-07	1.98e-05	CbGpPWpGaD
